secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K/A
Filed at:   2025-09-16T23:59:59+00:00
Accession:  0001493152-25-013648
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa shareholders approve 10x authorized share increase and reverse split
-----------------------------------------------------------------------------

- Shareholders approved increase in authorized common shares from 100M to 1B (13.7M for, 3.0M against).
- Reverse stock split approved with ratio ranging from 1:2 to 1:50, at board's discretion, by Dec 31, 2026.
- Amendment to 2019 Omnibus Incentive Plan to increase shares available for issuance approved (13.6M for).
- All four proposals passed at special meeting held Sep 11, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225013648/0001493152-25-013648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225013648/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer